Company: BWAY
Filing Date: 2025-04-22
Form Type: 20-F
Source: 0001171843-25-002347
Chunk: 66

Company: Brainsway Ltd.
Filing Date: 2025-04-22
Form: 20-F
Item: Item 5
Chunk 66
---
 or other
proceedings could have a material adverse effect on our ability to compete in the marketplace. Intellectual property litigation and other
proceedings may also absorb significant management time. Consequently, we may not be able to manufacture, use, offer for sale, sell or
import our Deep TMS systems in the event of an infringement action.

Any claims we assert against perceived infringers
could provoke these parties to assert counterclaims against us alleging that we infringe their patents. In addition, in a patent infringement
proceeding, a court may decide that a patent of ours is invalid or unenforceable, in whole or in part, construe the patent’s claims
narrowly or refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the technology
in question. An adverse result in any litigation proceeding could put one or more of our patents at risk of being invalidated or interpreted
narrowly. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there
is a risk that some of our confidential information could be compromised by disclosure during this type of litigation.

In the event of patent infringement claims, or to
avoid potential claims, we may choose or be required to seek a license from a third party and would most likely be required to pay license
fees or royalties or both. These licenses may not be available on acceptable terms, or at all. Even if we were able to obtain a license,
the rights may be nonexclusive, which could potentially limit our competitive advantage. Ultimately, we could be prevented from commercializing
a product or be forced to cease some aspect of our business operations if, as a result of actual or threatened patent infringement or
other claims, we are unable to enter into licenses on acceptable terms. This inability to enter into licenses could harm our business
significantly.

In addition, because of our developmental stage,
claims that Deep TMS infringes on the patent rights of others are more likely to be asserted after commencement of commercial sales incorporating
our technology.

In addition to infringement claims against us, we
may become a party to other patent litigation or proceedings before regulatory agencies, including post-grant review, inter parties review,
interference or re-examination proceedings filed with the U. S. Patent and Trademark Office that challenge our patent rights or the patent
rights of our licensors. The costs of defending our patents or enforcing our proprietary rights in post-issuance administrative proceedings
can be